Lysomal Acid Lipase Deficiency or LAL, A Rare Disease
January 1, 2013
Behind the mystery of rare & genetic diseases
Synageva believes every second counts when developing life-changing orphan treatments. Our current lead program focuses on enzyme replacement therapy for Lysomal Acid Lipase Deficiency or LAL. Tune-in to Lifetime Television’s The Balancing Act as this popular cable television show is joined by noted metabolic geneticist and physician, Doctor Olaf Bodamer from The University of Miami. This lively, informative segment explores and examines what’s being done for this debilitating disease – a condition which affects the liver and attack all age groups including newborn infants. This close-up and personal features two women – a mother whose daughter fought the disease and lost her battle, and a young woman currently battling LAL.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.